{
  "Variants Include": [
    {
      "Gene": "PARK7",
      "variants": [
        {
          "HGVS": "NM_001126112.3:c.77G>A",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "G",
            "alt": "A",
            "position": "77"
          },
          "Protein Change": {
            "ref": "M",
            "alt": "I",
            "position": "26"
          },
          "Description in input context": "M26I"
        },
        {
          "HGVS": "NM_001126112.3:c.497C>T",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "C",
            "alt": "T",
            "position": "497"
          },
          "Protein Change": {
            "ref": "L",
            "alt": "P",
            "position": "166"
          },
          "Description in input context": "L166P"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:000167"
  },
  "Experiment Method": [
    {
      "Assay Method": "Yeast two-hybrid screening",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "Neuroblastoma cells",
        "Description": "Protein-protein interaction analysis using yeast two-hybrid screening."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_001126112.3:c.77G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Impaired TTRAP interaction",
          "Result Description": "TTRAP binding to M26I variant was reduced compared to wild-type DJ-1."
        },
        {
          "Variant": "NM_001126112.3:c.497C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Impaired TTRAP interaction",
          "Result Description": "TTRAP binding to L166P variant was reduced compared to wild-type DJ-1."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each interaction assay was repeated in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type DJ-1 was used as a positive control for TTRAP interaction."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "A non-interacting protein was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Student's t-test was used to compare interaction levels between variants."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "TTRAP binding detected in at least 80% of replicates.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "TTRAP binding detected in less than 20% of replicates.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "No"
      }
    },
    {
      "Assay Method": "Apoptosis assay",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "Neuroblastoma cells",
        "Description": "Assessment of cell viability and apoptosis after proteasome inhibition."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001126112.3:c.77G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Increased apoptosis",
          "Result Description": "M26I variant caused 40% higher apoptosis compared to wild-type DJ-1."
        },
        {
          "Variant": "NM_001126112.3:c.497C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Increased apoptosis",
          "Result Description": "L166P variant caused 35% higher apoptosis compared to wild-type DJ-1."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each apoptosis assay was repeated in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Proteasome inhibitor treatment was used as a positive control for apoptosis."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Untreated cells were used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used to compare apoptosis levels between groups."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Apoptosis level less than 10% of control cells.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Apoptosis level greater than 30% of control cells.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}